Chief Medical Officer · AGIOS PHARMACEUTICALS, INC. · AGIOS PHARMACEUTICALS, INC. — Stock options (right to buy)
Side
M
Value
—
Shares
1,489
Price
—
Executed
Oct 21, 2026
Disclosed
Oct 23, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Oct 21 executedOct 23, 2026 disclosed
AGIO · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 6.4% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
AGIOS PHARMACEUTICALS, INC. — Stock options (right to buy)
Ticker
AGIO
Shares
1,489
Price per share
$0
Execution date (reported)
Oct 21, 2026
Owned after transaction
24.6K shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
2
What this establishes
Gheuens Sarah filed this Form 4 reporting a option exercise of AGIO on Oct 21, 2026. It became public on Oct 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Gheuens Sarahcik:0001881190
Issuer
AGIOS PHARMACEUTICALS, INC.cik:0001439222
Revision history · 0
No field has changed since this record was first ingested.
